Want to see PBSV full AI Analyst Report?
PBSV Stock Chart & Stats
$0.54
-$0.16(-27.16%)
At close: 4:00 PM EDT
$0.54
-$0.16(-27.16%)
Day’s Range― - ―
52-Week Range$0.41 - $1.36
Previous CloseN/A
Volume2.51K
Average Volume (3M)1.78K
Market Cap
$12.37M
Enterprise Value$11.26M
Total Cash (Recent Filing)$8.47M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.26
Next Earnings
Sep 16, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend Yield15.31%
Share Statistics
EPS (TTM)-0.37
Shares Outstanding22,901,691
10 Day Avg. Volume1,610
30 Day Avg. Volume1,782
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)1.04
Price to Sales (P/S)1.38
P/FCF Ratio-55.94
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue1.24
Enterprise Value/Gross Profit3.82
Enterprise Value/Ebitda-96.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.07
Revenue Forecast (FY)$11.70M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetMinimal leverage limits interest and refinancing risk, giving the company greater financial flexibility to manage operating volatility and fund corrective actions. This balance-sheet resilience is a durable offset to weak recent cash generation.
Healthy Gross MarginA gross margin near 33% indicates the underlying service offering retains meaningful value after direct costs. If maintained, this provides room to absorb overhead, support reinvestment, and improve earnings as operating execution stabilizes.
Positive TTM Net MarginThe positive TTM net margin shows the business can produce bottom-line profitability under recent conditions. Although the rebound requires confirmation because prior results were volatile, it provides an earnings base that could support future improvement.
Bears Say
Recurring Cash BurnSustained negative operating and free cash flow can constrain self-funded growth and increase execution risk, even without significant debt. Continued cash burn may reflect working-capital pressure or elevated operating needs that need to be corrected.
Declining Revenue TrendNegative revenue growth signals weakening demand, reduced project activity, or customer pressure. Without renewed top-line expansion, the company has less opportunity to leverage its cost base, improve margins, and make the recent earnings rebound durable.
Volatile Earnings QualityLarge swings between profits and losses, combined with near-zero EBIT margin, make recent earnings difficult to assess as a stable operating trend. This uncertainty raises the risk that TTM profitability will not persist without stronger core execution.
Pharma Bio Services News
PBSV FAQ
What was Pharma Bio Services’s price range in the past 12 months?
Pharma Bio Services lowest stock price was $0.41 and its highest was $1.36 in the past 12 months.
What is Pharma Bio Services’s market cap?
Pharma Bio Services’s market cap is $12.37M.
When is Pharma Bio Services’s upcoming earnings report date?
Pharma Bio Services’s upcoming earnings report date is Sep 16, 2026 which is in 5 days.
How were Pharma Bio Services’s earnings last quarter?
Pharma Bio Services released its earnings results on Jun 15, 2026. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by -$0.02.
Is Pharma Bio Services overvalued?
According to Wall Street analysts Pharma Bio Services’s price is currently Overvalued.
Does Pharma Bio Services pay dividends?
Pharma Bio Services pays a Notavailable dividend of $0.075 which represents an annual dividend yield of 15.31%. See more information on Pharma Bio Services dividends here
What is Pharma Bio Services’s EPS estimate?
Pharma Bio Services’s EPS estimate is 0.03.
How many shares outstanding does Pharma Bio Services have?
Pharma Bio Services has 22,901,691 shares outstanding.
What happened to Pharma Bio Services’s price movement after its last earnings report?
Pharma Bio Services reported an EPS of $0.01 in its last earnings report, missing expectations of $0.03. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pharma Bio Services?
Currently, no hedge funds are holding shares in PBSV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Pharma Bio Services
Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including those in the pharmaceutical, chemical, biotechnology, medical device, cosmetic, and food industries, as well as related product companies. Its operational reach extends across Puerto Rico, the United States, Europe, and Brazil. The firm's technical advisory offerings encompass vital areas such as regulatory adherence, system validation, technology migration, engineering solutions, comprehensive project management, and ongoing process support. Established in 1993, Pharma-Bio Serv maintains its corporate headquarters in Dorado, Puerto Rico.
Technical Analysis
Zhongchao
―
Healthcare Triangle
―
VSee Health
―
Aclarion, Inc.
―
BullFrog AI Holdings, Inc.
―